Amid rising concern over long-term use and side effects, France has launched a national campaign to raise awareness about the risks associated with commonly prescribed anti-anxiety and sleep medications such as Xanax, Lexomil and Temesta.
France's National Agency for the Safety of Medicines and Health Products (ANSM) has launched an awareness campaign to highlight the hidden dangers of benzodiazepines – a class of drugs that includes common medications such as Xanax, Lexomil and Temesta, which are frequently prescribed for anxiety and sleep disorders.
